Ascorbic acid (vitamin C) and iloprost attenuate the lung injury caused by ischemia/reperfusion of the lower extremities of rats

Annals of Vascular Surgery

Volumn 20, Issue 1, 2006, Pages 49-55

  Baltalarli, Ahmet ^a   Ozcan, Vefa ^a   Ferda, Bir ^a   Aybek, Hulya ^a   Sacar, Mustafa ^a   Onem, Gokhan ^a   Goksin, Ibrahim ^a   Demir, Suleyman ^a   Zafer, Teke ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; ILOPROST; MALONALDEHYDE; REDOXAN;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTERIAL OXYGEN TENSION; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CANNULA; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOPATHOLOGY; ISCHEMIA; JUGULAR VEIN; LEG; LEUKOCYTE; LUNG INJURY; LUNG PARENCHYMA; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION; STATISTICAL SIGNIFICANCE; STERNOTOMY;

EID: 29744433829     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-9284-0     Document Type: Article

References (40)

1. Klausner JM, Anner H, Paterson IS, et al. Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg 1988;208:761-767.
2. Homer-Vanniasinkam S, Crinnion JN, Gough MJ. Post-ischaemic organ dysfunction: a review. Eur J Vasc Endovasc Surg 1997;14:195-203.
3. Lindemann S, Gierer C, Darius H. Prostacyclin inhibits adhesion of polymorphonuclear leukocytes to human vascular endothelial cells due to adhesion molecule independent regulatory mechanisms. Basic Res Cardiol 2003;98:8-15.
4. Draper HH, Hadley M. Malonaldehyde determination as index of lipid peroxidation In: Parcker, L, Glazer, A (eds), Methods in Enzymology. vol 186. New York: Academic Press, 1991, pp 421-431.
5. Goldfarb AH, McIntosh MK, Boyer BT. Vitamin E effects on indexes of lipid peroxidation in muscle from DHEA-treated and exercised rats. J Appl Physiol 1994;76:1630-1635.
6. Blebea J, Cambria RA, DeFouw D, Feinberg RN, Hobson RW, Duran WN. Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J Vasc Surg 1990;12:657-665.
7. Thomson IA, Egginton S, Slimms MH, Hudlicka O. Effect of muscle ischemia and iloprost during femorodistal reconstruction on capillary endothelial swelling. Int J Microcirc Clin Exp 1996;16:284-290.
8. McNamara DB, Champion HC, Kadowitz PJ. Nonoperative management of lower extremity arterial disease. Part I. Pharmocologic management of peripheral vascular disease. Surg Clin North Am 1998;78:447-456.
9. Kawashima M, Nakamura T, Schneider S, et al. Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance. J Heart Lung Transplant 2003;22:794-801.
10. Lehr HA, Frei B, Olofsson M. Protection from oxidised LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 1995;91:1525-1532.
11. Winklhofer-Roob BM, Ellemunter H, Fruwirth M. Plasma vitamin C concentration in patients with cystic fibrosis: evidence of associations with lung inflammation. Am J Clin Nutr 1997;65:1858-1866.
12. Institute of Laboratory Animal Resources, National Research Council. Guide for the Care and Use of Laboratory Animals. Washington DC: National Academy Press, 1996.
13. Yagi K. Lipid peroxides and related radicals in clinical medicine In: Armstrong, D (ed), Free Radicals in Diagnostic Medicine. New York: Plenum Press, 1994, pp 1-15.
14. Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
15. Calikoglu M, Tamer M, Sucu N, et al. The effects of caffeic acid phenethyl ester on tissue damage in lung after hindlimb ischemia-reperfusion. Pharmacol Res 2003;48:397-403.
16. Smith GJ, Holcroft JW, Blaisdell FW. Acute arterial insufficiency In: Wilson, SE, Veith, F, Hobson, RW, Williams, RA (eds), Vascular Surgery. Principles and Practice. New York: McGraw Hill, 1987, pp 325-331.
17. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and reperfusion syndrome: a review. Cardivasc Surg 2002;10:620-630.
18. Akar H, Saraç, Konuralp C, Yildiz L, Kolbakir F. Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury. Eur J Cardiothorac Surg 2001;19:500-506.
19. Ferrante RJ, Hobson RW II, Miyasaka M, Granger DN, Duran WN. Inhibition of white blood cell adhesion at reperfusion decreases tissue damage in postischemic striated muscle. J Vasc Surg 1996;24:187-193.
20. Kurose I, Granger DN. Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann N Y Acad Sci 1994;723:158-179.
21. Hirose J, Yamaga M, Kato T, Ikebe K, Takagi K. Effects of hydroxyl radical scavenger, EPC-K1, and neutrophil depletion on reperfusion injury in rat skeletal muscle. Acta Orthop Scand 2001;72:404-410.
22. Schlag MG, Clarke S, Carson MW, Haris KA, Potter RF. The effect of mannitol versus dimethyl thiourea at attenuating ischemia/reperfusion induced injury to skeletal muscle. J Vasc Surg 1999;29:511-521.
23. Bozkurt AK. α-tocopheral (vitamin E) and iloprost attenuate reperfusion injury in skeletal muscle ischemia/reperfusion injury. J Cardiovasc Surg 2002;43:693-696.
24. Kanzig I, Cakici I, Ersoy S, Ark M, Abacioglu N, Zengil H. Effects of cyclooxygenase and lipooxygenase inhibitors on digoxin-induced arrhythmias and hemodynamics in guinea-pigs. Pharmacol Res 1992;26:305-316.
25. Seth SD, Maulik M, Manchanda SC, Maulik SK. Role of aspirin in modulating ischaemic reperfusion injury. Agents Actions 1994;41:151-155.
26. Curtis MJ, Pugsley MK, Walker MJA. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. Carediovasc Res 1993;27:703-719.
27. Herbaczynska-Cedro K, Wartanowicz M, Panczenko-Kresowska B. Inhibitory effect of vitamins C and E on the oxygen free radicals production in human polymorphonuclear leucocytes. Eur J Clin Invest 1994;24:316-319.
28. Grant SM, Goa KL. Iloprost Drugs 1992;43:889-924.
29. Tassiopoulos AK, Carlin RE, Gao Y. Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/ reperfusion of the lower extremities. J Vasc Surg 1997;26:647-656.
30. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-1023.
31. Araki H, Lefer AM. Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res 1980;47:757-763.
32. 1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 1983;113:506-512.
33. Riva CM, Morganroth ML, Ljungman AG, et al. Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am J Respir Cell Mol Biol 1990;3:301-309.
34. Katircioglu SF, Ulus AT, Gokce P, Sorucu S. Iloprost protects the spinal cord during aortic cross-clamping in a canine model. J Cardiovasc Surg 2000;41:89-93.
35. Silistreli E, Kabakci B, Yilmaz E, et al. Early protective effects of iloprost, a stable prostacyclin analog, during spinal cord ischemia in a rabbit model. Heart Vessels 2005;20:66-71.
36. Aitchison KA, Coker SJ. Potential interactions between iloprost and SIN-1 on platelet aggregation and myocardial infarct size in vivo. Eur J Pharmacol 1999;374:59-69.
37. Tadros T, Traber DL, Herndon DN. Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after bum and sepsis. Ann Surg 2004;239:67-74.
38. Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J Hepatol 2002;36:72-77.
39. Taha MO, Souza HS, Carvalho CA, et al. Cytoprotective effects of ascorbic acid on the ischemia-reperfusion injury of rat liver. Transplant Proc 2004;36:296-300.
40. Seekamp A, Ward PA. Ischemia-reperfusion injury. Agents Actions Suppl 1993;41:137-152.